Cannabinoid activation of PPARα; a novel neuroprotective mechanism

Baker, 2006, Insilico patent searching reveals a new cannabinoid receptor, Trends Pharmacol Sci, 27, 1, 10.1016/j.tips.2005.11.003

Berger, 2005, PPARs: therapeutic targets for metabolic disease, Trends Pharmacol Sci, 26, 244, 10.1016/j.tips.2005.03.003

Bouaboula, 2005, Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation, Eur J Pharmacol, 517, 174, 10.1016/j.ejphar.2005.05.032

Boussif, 1995, A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine, Proc Natl Acad Sci USA, 92, 7297, 10.1073/pnas.92.16.7297

Breivogel, 2001, Evidence for a new G protein-coupled cannabinoid receptor in mouse brain, Mol Pharmacol, 60, 155, 10.1124/mol.60.1.155

Burstein, 2005, PPAR-γ: a nuclear receptor with affinity for cannabinoids, Life Sci, 77, 1674, 10.1016/j.lfs.2005.05.039

Causevic, 1999, Substitution of a conserved amino acid residue alters the ligand binding properties of peroxisome proliferator activated receptors, FEBS Lett, 463, 205, 10.1016/S0014-5793(99)01618-X

Clement, 2003, Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase, J Neurosci, 23, 3916, 10.1523/JNEUROSCI.23-09-03916.2003

Contassot, 2004, Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1, Gynecol Oncol, 93, 182, 10.1016/j.ygyno.2003.12.040

Cota, 2003, Endogenous cannabinoid system as a modulator of food intake, Int J Obes Relat Metab Disord, 27, 289, 10.1038/sj.ijo.0802250

Cota, 2003, The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis, J Clin Invest, 112, 423, 10.1172/JCI17725

Deplanque, 2003, Peroxisome proliferator-activated receptor-α activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment, J Neurosci, 23, 6264, 10.1523/JNEUROSCI.23-15-06264.2003

Di Marzo, 2004, The endocannabinoid system and its therapeutic exploitation, Nat Rev Drug Discov, 3, 771, 10.1038/nrd1495

Di Marzo, 2002, Anandamide receptors, Prostaglandins Leukot Essent Fatty Acids, 66, 377, 10.1054/plef.2001.0349

Duncan, 2004, Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 Gi/o linked receptor, Br J Pharmacol, 142, 509, 10.1038/sj.bjp.0705789

Fan, 2003, Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55212-2, Vis Neurosci, 20, 177, 10.1017/S095252380320208X

Fu, 2003, Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α, Nature, 425, 90, 10.1038/nature01921

Gibson, 2004, Progesterone enhances functional recovery after middle cerebral artery occlusion in male mice, J Cereb Blood Flow Metab, 24, 805, 10.1097/01.WCB.0000125365.83980.00

Guzman, 2004, Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor α (PPAR-α), J Biol Chem, 279, 27849, 10.1074/jbc.M404087200

Hajos, 2001, Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus, Neuroscience, 106, 1, 10.1016/S0306-4522(01)00287-1

Howlett, 1995, Pharmacology of cannabinoid receptors, Annu Rev Pharmacol Toxicol, 35, 607, 10.1146/annurev.pa.35.040195.003135

Howlett, 2002, The cannabinoid receptors, Prostaglandins Other Lipid Mediat, 6869, 619, 10.1016/S0090-6980(02)00060-6

Howlett, 2002, International Union of Pharmacology. XXVII. Classification of cannabinoid receptors, Pharmacol Rev, 54, 161, 10.1124/pr.54.2.161

Iadecola, 2001, Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice, Proc Natl Acad Sci USA, 98, 1294, 10.1073/pnas.98.3.1294

Jarai, 1999, Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors, Proc Natl Acad Sci USA, 96, 14136, 10.1073/pnas.96.24.14136

Jonsson, 2001, Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide, Br J Pharmacol, 133, 1263, 10.1038/sj.bjp.0704199

Lambert, 1999, Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB2 cannabinoid, as potential ligands for the cannabinoid receptors, Biochim Biophys Acta, 1440, 266, 10.1016/S1388-1981(99)00132-8

Lin, 1998, Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability, J Med Chem, 41, 5353, 10.1021/jm970257g

Lo Verme, 2005, The nuclear receptor peroxisome proliferator-activated receptor-α mediates the antiinflammatory actions of palmitoylethanolamide, Mol Pharmacol, 67, 15, 10.1124/mol.104.006353

Maccarrone, 2002, Endocannabinoids and their actions, Vitam Horm, 65, 225, 10.1016/S0083-6729(02)65066-6

Maccarrone, 2003, The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis, Cell Death Differ, 10, 946, 10.1038/sj.cdd.4401284

Mackie, 2006, Cannabinoid receptors as therapeutic targets, Annu Rev Pharmacol Toxicol, 46, 101, 10.1146/annurev.pharmtox.46.120604.141254

Miettinen, 1997, Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2, Proc Natl Acad Sci USA, 94, 6500, 10.1073/pnas.94.12.6500

Nagayama, 1999, Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures, J Neurosci, 19, 2987, 10.1523/JNEUROSCI.19-08-02987.1999

Nakayama, 1998, Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia, Proc Natl Acad Sci USA, 95, 10954, 10.1073/pnas.95.18.10954

Nogawa, 1997, Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage, J Neurosci, 17, 2746, 10.1523/JNEUROSCI.17-08-02746.1997

O'Neill, 1997, NF-κB: a crucial transcription factor for glial and neuronal cell function, Trends Neurosci, 20, 252, 10.1016/S0166-2236(96)01035-1

O'Sullivan, 2005, Novel time-dependent vascular actions of Δ9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor γ, Biochem Biophys Res Commun, 337, 824, 10.1016/j.bbrc.2005.09.121

Overton, 2006, Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents, Cell Metab, 3, 167, 10.1016/j.cmet.2006.02.004

Panikashvili, 2005, CB1 cannabinoid receptors are involved in neuroprotection via NF-κB inhibition, J Cereb Blood Flow Metab, 25, 477, 10.1038/sj.jcbfm.9600047

Salminen, 1995, Alteration of transcription factor binding activities in the ischemic rat brain, Biochem Biophys Res Commun, 212, 939, 10.1006/bbrc.1995.2060

Schneider, 1999, NF-κB is activated and promotes cell death in focal cerebral ischemia, Nat Med, 5, 554, 10.1038/8432

Seo, 2002, Selective uptake from LDL is stimulated by unsaturated fatty acids and modulated by cholesterol content in the plasma membrane: role of plasma membrane composition in regulating non-SR-BI-mediated selective lipid transfer, Biochemistry, 41, 7885, 10.1021/bi011949g

Staels, 1998, Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators, Nature, 393, 790, 10.1038/31701

Steffens, 2005, Binding affinity and agonist activity of putative endogenous cannabinoids at the human neocortical CB1 receptor, Biochem Pharmacol, 69, 169, 10.1016/j.bcp.2004.08.033

Turk, 2004, In vitro transfection of HeLa cells with temperature sensitive polycationic copolymers, J Control Release, 96, 325, 10.1016/j.jconrel.2004.01.013

Wang, 2004, Conversion of human-selective PPAR alpha agonists to human/mouse dual agonists: a molecular modeling analysis, Bioorg Med Chem Lett, 14, 6113, 10.1016/j.bmcl.2004.09.031

Yang, 1995, Increased cortical nuclear factor-kappa B (NF-κB) DNA binding activity after traumatic brain injury in rats, Neurosci Lett, 197, 101, 10.1016/0304-3940(95)11919-N

Zygmunt, 1999, Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide, Nature, 400, 452, 10.1038/22761